Clinical Trial Update: Early Assessment of Response to Treatment of Metastatic LUng Tumors Based on CIrculating Tumor DNA [NA]

View source ↗

Summary

A completed clinical trial update evaluating early response to treatment in metastatic non-small cell lung cancer using circulating tumor DNA as a biomarker to …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Centre Hospitalier Departemental Vendee | Conditions: Metastatic Non-small Cell Lung Cancer | NA | Status: COMPLETED